Gammalon 250 mg 100 tablets

The active substance is Gamma-aminobutyric acid.

Pharmacological action

Stimulating metabolism in the central nervous system, nootropic. Improves blood supply to the brain, activates energy processes, increases the respiratory activity of tissues, improves glucose utilization and removal of toxic metabolic products. It improves the dynamics of nervous processes in the brain, increases the productivity of thinking, improves memory, has a moderate psychostimulating, antihypoxic and anticonvulsant effect. It helps to restore speech and motor functions after impaired cerebral circulation. It has a moderate hypotensive effect, reduces the initially elevated blood pressure and the severity of symptoms caused by hypertension (dizziness, insomnia), slightly reduces the heart rate. In patients with diabetes mellitus, it reduces blood glucose levels, and with normal glycemia it often causes hyperglycemia due to glycogenolysis. The plasma concentration is reached after a maximum of 60 minutes, then decreases rapidly; after 24 hours, it is not detected in the blood plasma. It is low-toxic.

Indications for use

Cerebral vascular damage (atherosclerosis, hypertension, etc.), cerebrovascular insufficiency and dyscirculatory encephalopathy, impaired memory, attention, speech, dizziness, headache, consequences of stroke and traumatic brain injury, alcoholic encephalopathy, alcoholic polyneuritis, mental retardation in children, dementia, cerebral palsy, endogenous depression with a predominance asthenoipochondriacal phenomena and difficulty in mental activity, a symptom complex of motion sickness (sea and air sickness).

Contraindications

Hypersensitivity, childhood (under 1 year), acute renal failure, pregnancy (I trimester)

Side effect

Nausea, vomiting, insomnia, fluctuations in blood pressure (in the first days of treatment), dyspepsia, hyperthermia, a feeling of heat.

Manufacturer

ALFRESA Japan